Related Experiment Video
Updated: Nov 20, 2025
11:38
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
12.5K
Expanding the toxicologist's statistical toolbox: Using effect size estimation and dose-response modelling for
Felix M Kluxen1, Signe M Jensen2
1ADAMA Deutschland GmbH, Cologne, Germany.
Regulatory Toxicology and Pharmacology : RTP
|January 24, 2021
Summary
Relying solely on statistical significance tests for toxicological assays can be misleading. Dose-response modeling and biological plausibility are crucial for accurate assessments, especially with complex data.
Area of Science:
- Environmental toxicology
- Statistical analysis in science
Background:
- Null hypothesis statistical testing (NHST) is often used for toxicological assay evaluation.
- Uncritical application of NHST can lead to biased assessments.
- NHST relies on assumptions and may not suit all data types.
Purpose of the Study:
- To investigate the impact of unreflected statistical testing on toxicological assessments.
- To compare traditional statistical tests with dose-response modeling.
- To highlight the importance of biological plausibility in toxicological evaluations.
Main Methods:
- Comparison of Dunnett multiple-comparison and Williams trend testing with compatibility intervals.
- Application of dose-response modeling.
- Case studies with non-ideal toxicological data.
Main Results:
- p-value-based assessments can be biased when data deviate from expected patterns.
- Dose-response modeling offers a more robust evaluation in complex cases.
- Biological plausibility should guide toxicological interpretation.
Conclusions:
- Toxicological assessments should not solely rely on statistical significance.
- Dose-response modeling and biological plausibility are essential for accurate interpretation.
- Further data may be required for robust conclusions, especially for negative outcomes.
Keywords:
Benchmark doseDose-response modellingEffect size estimationHazard characterizationHazard identificationStatistical significanceStatistical testingMore Related Videos
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
14.4K
06:25Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
Published on: January 12, 2024
1.9K
Related Concept Videos
01:21Dose Size and Dosing Frequency: Determination Methods
102
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
102
01:03Dose-Response Relationship: Overview
4.4K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
266
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
266
01:26Pharmacokinetic Models: Comparison and Selection Criterion
218
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
218
01:22Dose-Response Relationship: Potency and Efficacy
6.0K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.0K
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
59
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
59